Mahtab MA, Tabassum S, Nesa A, Jahan M, Khan MSI, Akbar SMF. A new therapeutic option for chronic hepatitis B: Reduced dose and shorter duration of a combination therapy with pegylated interferon and entecavir. Bangladesh Med Res Counc Bull [Internet]. 2019 Dec. 30 [cited 2024 Sep. 27];45(3):143-8. Available from: https://banglajol.info/index.php/BMRCB/article/view/44643